Cervicovaginal microbiome and natural history of HPV in a longitudinal studyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This longitudinal study asked how the cervicovaginal microbiome shapes the natural history of high-risk HPV infection: clearance, persistence, or progression to precancer. Cervical samples from two visits were analyzed. Bacteria were profiled by 16S V4 rRNA sequencing and fungi by ITS1 sequencing on Illumina MiSeq. The team used LEfSe biomarkers, generalized linear models adjusted for age, smoking, HPV16, and community state type, plus mediation analysis. Functional pathways were imputed with PICRUSt.
Who was studied?
The cohort was 273 women aged 18 to 25 years with an incident high-risk HPV infection, drawn from the placebo arm of the Costa Rica HPV Vaccine Trial. Of these, 266 had a second sample, averaging 1.5 years apart. Outcomes were clearance (70 women), persistence (170), and progression to CIN2 or CIN3 (33). Samples were cervical brush specimens. This was a nested analysis within a randomized controlled trial in Costa Rica.
What were the most important findings?
At the first visit, Lactobacillus iners abundance tracked with HPV clearance while Gardnerella was the dominant biomarker for progression (LDA greater than 4.0). At the second visit, rising Shannon diversity was significantly linked to progression to CIN2+ (p = 0.024). In adjusted models, first-visit Lactobacillus was protective (odds ratio 0.41, 95% CI 0.22 to 0.79), as were fungal diversity and a bacterial cell motility pathway. Second-visit bacterial diversity was a risk factor (odds ratio around 1.17 to 1.19). Mediation analysis showed Gardnerella's link to progression was explained by the later rise in diversity (p = 0.040 for the mediator).
What are the greatest implications of this study?
The findings suggest Gardnerella does not directly cause precancer but promotes it by expanding cervicovaginal diversity over time, which then drives progression. Lactobacillus and greater fungal diversity appeared protective. This prospective design lets the authors propose a causal-style model, though they stress causation is not established. Monitoring Gardnerella and subsequent diversity could help flag women with persistent HPV at higher risk. The microbiome may become a target for therapeutic manipulation to prevent CIN2+.